Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/35935
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJoao, Esau
dc.contributor.authorGouvea, Maria I.
dc.contributor.authorFreimanis-Hance, Laura
dc.contributor.authorCohen, Rachel A.
dc.contributor.authorRead, Jennifer S.
dc.contributor.authorMelo, Victor
dc.contributor.authorDuarte, Geraldo
dc.contributor.authorIvalo, Silvina
dc.contributor.authorMachado, Daisy M. [UNIFESP]
dc.contributor.authorPilotto, Jose
dc.contributor.authorSiberry, George K.
dc.contributor.authorNISDI LILAC Protocol
dc.date.accessioned2016-01-24T14:31:13Z-
dc.date.available2016-01-24T14:31:13Z-
dc.date.issued2013-02-01
dc.identifierhttp://dx.doi.org/10.1016/j.ijgo.2012.08.017
dc.identifier.citationInternational Journal of Gynecology & Obstetrics. Clare: Elsevier B.V., v. 120, n. 2, p. 144-147, 2013.
dc.identifier.issn0020-7292
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/35935-
dc.description.abstractObjective: To describe Group B Streptococcus (GBS) prevention policies at 12 Latin American sites participating in the NICHD (Eunice Kennedy Shriver National Institute of Child Health and Human Development) International Site Development Initiative (NISDI) Longitudinal Study in Latin American Countries (LILAC) and to determine rates of rectovaginal colonization and GBS-related disease among HIV-infected pregnant women and their infants. Methods: Site surveys were used to assess prevention policies and practices administered cross-sectionally during 2010. Data collected in NISDI from 2008 to 2010 regarding HIV-infected pregnant women were used to determine rates of colonization and GBS-related disease. Results: of the 9 sites with a GBS prevention policy, 7 performed routine rectovaginal screening for GBS. of the 401 women included in the NISDI study, 56.9% were at sites that screened. the GBS colonization rate was 8.3% (19/228 women; 95% confidence interval [CI], 5.1%-12.7%). Disease related to GBS occurred in 0.5% of the participants (2/401 women; 95% CI, 0.1%-1.8%); however, no GBS-related disease was reported among the 398 infants (95% CI, 0.0%-0.9%). Conclusion: Improved efforts to implement prevention policies and continued surveillance for GBS are needed to understand the impact of GBS among HIV-infected pregnant women and their infants in Latin America. (c) 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.en
dc.description.sponsorshipEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
dc.format.extent144-147
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofInternational Journal of Gynecology & Obstetrics
dc.rightsAcesso restrito
dc.subjectGroup B Streptococcusen
dc.subjectInfection ratesen
dc.subjectInstitutional policyen
dc.subjectMaternal HIVen
dc.subjectPregnancyen
dc.titleInstitutional prevention policies and rates of Group B Streptococcus infection among HIV-infected pregnant women and their infants in Latin Americaen
dc.typeArtigo
dc.rights.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.contributor.institutionHosp Fed Serv Estado Rio de Janeiro
dc.contributor.institutionInst Pesquisa Clin Evandro Chagas IPEC FIOCRUZ
dc.contributor.institutionWestat Corp
dc.contributor.institutionEunice Kennedy Shriver Natl Inst Child Hlth & Hum
dc.contributor.institutionNatl Vaccine Program Off
dc.contributor.institutionUniversidade Federal de Minas Gerais (UFMG)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionHosp Gen Agudos Jose Maria Ramos Mejia
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionHosp Geral Nova Iguacu
dc.contributor.institutionFiocruz MS
dc.description.affiliationHosp Fed Serv Estado Rio de Janeiro, Serv Doencas Infecciosas & Parasit, BR-20221903 Rio de Janeiro, Brazil
dc.description.affiliationInst Pesquisa Clin Evandro Chagas IPEC FIOCRUZ, Rio de Janeiro, Brazil
dc.description.affiliationWestat Corp, Rockville, MD USA
dc.description.affiliationEunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Adolescent & Maternal AIDS Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD USA
dc.description.affiliationNatl Vaccine Program Off, Off Assistant Secretary Hlth, Off Secretary, Dept Hlth & Human Serv, Washington, DC USA
dc.description.affiliationUniv Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil
dc.description.affiliationUniv São Paulo, Fac Med Ribeirao Preto, Hosp Clin, Dept Gynecol & Obstet, São Paulo, Brazil
dc.description.affiliationHosp Gen Agudos Jose Maria Ramos Mejia, Buenos Aires, DF, Argentina
dc.description.affiliationUniversidade Federal de São Paulo, Escola Paulista Med, São Paulo, Brazil
dc.description.affiliationHosp Geral Nova Iguacu, HIV Family Care Clin, Nova Iguacu, Brazil
dc.description.affiliationFiocruz MS, Inst Oswald Cruz, AIDS & Mol Immunol Lab, BR-21045900 Rio de Janeiro, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Escola Paulista Med, São Paulo, Brazil
dc.description.sponsorshipIDEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): HHSN267200800001C
dc.description.sponsorshipIDEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): N01-HD-8-0001
dc.identifier.doi10.1016/j.ijgo.2012.08.017
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000314433400009
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.